FDA Tells Watson, Swedish Drugmaker To Pull Misleading Ads
The U.S. Food and Drug Administration told Watson Pharmaceuticals Inc. and Swedish Orphan Biovitrum AB to stop publishing allegedly misleading advertisements for their anemia treatment and cancer-related mucositis drugs, respectively, according...To view the full article, register now.
Already a subscriber? Click here to view full article